MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,522,521 | -53.0% | 6,591 | -75.9% | 0.02% | -46.4% |
| Q3 2020 | $3,241,000 | -60.2% | 27,299 | -62.0% | 0.03% | -61.1% |
| Q2 2020 | $8,144,000 | +31.3% | 71,914 | -22.6% | 0.07% | +2.9% |
| Q1 2020 | $6,203,000 | +25.6% | 92,912 | +71.4% | 0.07% | +94.4% |
| Q4 2019 | $4,938,000 | +166.6% | 54,200 | +152.3% | 0.04% | +140.0% |
| Q3 2019 | $1,852,000 | -35.7% | 21,482 | -21.8% | 0.02% | -31.8% |
| Q2 2019 | $2,880,000 | -73.8% | 27,475 | -68.7% | 0.02% | -71.8% |
| Q1 2019 | $10,986,000 | +16.2% | 87,703 | +4.6% | 0.08% | +2.6% |
| Q4 2018 | $9,454,000 | – | 83,868 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |